Results 111 to 120 of about 4,355,851 (162)

Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1

open access: yes, 1992
SUMMARY The majority of the immunodominant amino acid sequences of HIV-I that have been characterized to date are coded for by hypervariable gene sequences.
D A COOPER   +4 more
core   +1 more source

Membrane Structure Correlates to Function of LLP2 on the Cytoplasmic Tail of HIV-1 GP41 Protein

open access: yes, 2018
Mutation studies previously showed that the lentivirus lytic peptide (LLP2) sequence of the cytoplasmic C-terminal tail of the HIV-1 gp41 envelope protein inhibited viral-initiated T-cell death and T-cell syncytium formation, at which time in the HIV ...
Jonathan D. Steckbeck (43112)   +7 more
core   +1 more source

Correction: Effects of the I559P gp41 Change on the Conformation and Function of the Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimer

open access: yes, 2015
Correction: Effects of the I559P gp41 Change on the Conformation and Function of the Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein ...
PLOS ONE (2189197)
core   +1 more source

Recombinant E2340-Fc protein and E2-derived peptides bind HIV-1 gp41.

open access: yes, 2013
(A) 293T cells expressing NL4-3 envelope (X4env) or empty plasmid as control were incubated with sCD4 and FITC-conjugated E2 peptides, respectively. Peptide binding was analyzed by flow cytometry.
Bernhard Fleckenstein (275876)   +9 more
core   +1 more source

Stable expression of HIV-1 MPER extended epitope on the surface of the recombinant probiotic bacteria Escherichia Coli Nissle 1917 using CRISPR/Cas9

open access: yesMicrobial Cell Factories
Background Mucosal vaccines have the potential to induce protective immune responses at the sites of infection. Applying CRISPR/Cas9 editing, we aimed to develop a probiotic-based vaccine candidate expressing the HIV-1 envelope membrane-proximal external
Nathaniel Ninyio   +5 more
doaj   +1 more source

Using a Drug Repurposing Strategy to Virtually Screen Potential HIV-1 Entry Inhibitors That Block the NHR Domain of the Viral Envelope Protein gp41

open access: yesMathematical Biology and Bioinformatics
Using a drug repurposing strategy, virtual screening of potential inhibitors of the NHR domain of the HIV-1 gp41 protein, a conserved region critical for the virus-cell membrane fusion and viral infectivity, was carried out. The used computational approach included: (1) molecular docking of this functionally significant region of the HIV-1 envelope ...
A.M. Andrianov   +2 more
openaire   +1 more source

Model for the structure of the HIV gp41 ectodomain: insight into the intermolecular interactions of the gp41 loop

open access: yes, 2001
In human immunodeficiency virus (HIV) the viral envelope proteins gp41 and gp120 form a non-covalent complex, which is a potential target for AIDS therapies. In addition gp41 plays a possible role in HIV infection of B cells via the complement system. In
Caffrey, Michael
core   +1 more source

Characterization and epitope mapping of KI-41, a murine monoclonal antibody specific for the gp41 envelope protein of the human immunodeficiency virus-1

open access: yes, 1998
In this study, a mouse monoclonal antibody (mAb) against gp41(584-618), the immunodominant epitope of HIV-1 gp41 envelope protein, was generated. For this purpose, BALB/c mice were immunized with double branched multiple antigenic peptides derived from ...
Myung Kyu Lee   +4 more
core  

Targeted expression of the anti-HIV microbicide lectin griffithsin in maize and tobacco [PDF]

open access: yes, 2013
Includes abstract.Includes bibliographical references.Plants are emerging as cost friendly alternative production systems for a variety of pharmaceuticals. Numerous therapeutic proteins have been produced in plant systems (Giddings et al., 2000; Ma et al.
Stark, Hester Catharina (Therese)
core   +1 more source

Home - About - Disclaimer - Privacy